Rhythm Pharmaceuticals Price To Sales Over Time
| RYTM Stock | USD 56.12 0.64 1.15% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Rhythm Pharmaceuticals Performance and Rhythm Pharmaceuticals Correlation. Rhythm |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rhythm Pharmaceuticals. If investors know Rhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rhythm Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.32) | Revenue Per Share 1.863 | Quarterly Revenue Growth 0.478 | Return On Assets (0.46) | Return On Equity (1.48) |
The market value of Rhythm Pharmaceuticals is measured differently than its book value, which is the value of Rhythm that is recorded on the company's balance sheet. Investors also form their own opinion of Rhythm Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rhythm Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rhythm Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rhythm Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rhythm Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rhythm Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rhythm Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price To Sales Ratio Analysis
Compare Rhythm Pharmaceuticals and related stocks such as Revolution Medicines, Akero Therapeutics, and Avidity Biosciences Price To Sales Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RVMD | 52.2724 | 52.2724 | 52.2724 | 52.2724 | 52.2724 | 52.2724 | 52.2724 | 52.2724 | 52.2724 | 34.0746 | 61.3425 | 62.3521 | 54.2828 | 280 | 294 |
| AKRO | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| RNA | 1.6 K | 1.6 K | 1.6 K | 1.6 K | 1.6 K | 1.6 K | 1.6 K | 1.6 K | 1.6 K | 461 | 81.4557 | 106 | 125 | 69.117 | 65.66 |
| PTGX | 18.3445 | 18.3445 | 18.3445 | 18.3445 | 18.3445 | 18.3445 | 18.3445 | 18.3445 | 4.867 | 790 | 24.2222 | 57.91 | 20.1291 | 21.6931 | 20.61 |
| STOK | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 26.3568 | 30.42 |
| QURE | 63.2548 | 63.2548 | 63.2548 | 63.2548 | 44.5078 | 35.4122 | 5.5863 | 40.3311 | 91.026 | 394 | 42.8259 | 1.8201 | 9.9498 | 20.3707 | 19.35 |
| RCKT | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| SLDB | 13.7187 | 13.7187 | 13.7187 | 13.7187 | 13.7187 | 13.7187 | 13.7187 | 13.7187 | 13.7187 | 13.7187 | 13.7187 | 13.7187 | 5.6579 | 6.51 | 10.66 |
| MGTX | 49.9475 | 49.9475 | 49.9475 | 49.9475 | 49.9475 | 49.9475 | 49.9475 | 49.9475 | 49.9475 | 49.9475 | 36.6989 | 27.7944 | 18.5025 | 28.2896 | 35.48 |
| NUVL | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| VTYX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ACLX | 24.1791 | 24.1791 | 24.1791 | 24.1791 | 24.1791 | 24.1791 | 24.1791 | 24.1791 | 24.1791 | 24.1791 | 24.1791 | 24.1791 | 24.1791 | 21.76 | 19.34 |
| CGEM | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 32.47 | 28.86 |
| KNSA | 20.941 | 20.941 | 20.941 | 20.941 | 20.941 | 20.941 | 20.941 | 20.941 | 20.941 | 20.941 | 20.941 | 20.941 | 4.7204 | 4.5469 | 4.32 |
| PLRX | 13.2729 | 13.2729 | 13.2729 | 13.2729 | 13.2729 | 13.2729 | 13.2729 | 13.2729 | 13.2729 | 13.2729 | 19.3165 | 63.91 | 83.8583 | 673 | 707 |
| SNDX | 332 | 332 | 332 | 332 | 332 | 332 | 85.9208 | 87.256 | 74.4253 | 176 | 606 | 8.1577 | 8.1577 | 7.34 | 6.97 |
| INZY | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| RLAY | 21.4299 | 21.4299 | 21.4299 | 21.4299 | 21.4299 | 21.4299 | 21.4299 | 21.4299 | 21.4299 | 21.4299 | 21.4299 | 965 | 1.2 K | 52.8289 | 50.19 |
| BDTX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ARVN | 43.0292 | 43.0292 | 43.0292 | 43.0292 | 43.0292 | 43.0292 | 43.0292 | 43.9044 | 8.4532 | 31.4823 | 154 | 87.9443 | 13.8506 | 29.1004 | 41.18 |
Rhythm Pharmaceuticals and related stocks such as Revolution Medicines, Akero Therapeutics, and Avidity Biosciences Price To Sales Ratio description
Price to Sales Ratio is figured by comparing Rhythm Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Rhythm Pharmaceuticals sales, a figure that is much harder to manipulate than other Rhythm Pharmaceuticals multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
| Rhythm Pharmaceuticals | RYTM |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
USD 56.12
Check out Rhythm Pharmaceuticals Performance and Rhythm Pharmaceuticals Correlation. To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Rhythm Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.